Latest Conference Articles

Hure details what clinicians need to know to protect their patients.

The DERM 2025 midway recap includes tips for atopic dermatitis, chronic hand eczema, and pruritus.

Rheumatologist Karim Ladak, MD, shared diagnostic and treatment tips for cutaneous lupus at DERM 2025.

Catch up on coverage from the first day of the 2025 Elevate-Derm Summer Conference held in Park City, Utah.

Catch up on coverage from the first day of the 50th Annual Society for Pediatric Dermatology Meeting in Seattle, Washington.

Walter Liszewski, MD, highlights the clinical impact of patch testing and shares strategies for selecting and dosing JAK inhibitors at Elevate-Derm Summer.

Discover innovative research pearls at the Elevate-Derm Summer Conference 2025, focusing on psoriasis, skin cancer, and more.

Discover insights from SPD 2025 on pediatric obesity treatment, emphasizing multidisciplinary care and innovative therapies.

New findings at Elevate Derm highlight remibrutinib's rapid and sustained efficacy in reducing chronic spontaneous urticaria symptoms, offering hope for patients.

At the DERM 2025 conference, Scott Boswell, MD, shares tips for combining therapies.

James Song, MD, discussed his UnlIMMited DERM 2025 poster detailing risankizumab's efficacy for genital and scalp psoriasis.

Join Dermatology Times at the 2025 Elevate-Derm Summer Conference for expert insights and live updates from Park City, Utah.

Joe Gorelick, MSN, FNP-C, discusses upcoming highlights and new data expected at the upcoming DERM 2025 CME Conference.

We want to know: Will you be attending the conference in Seattle this week?

The 2025 Fall Clinical Dermatology Conference energized PAs and NPs with innovative strategies, addressing burnout, digital branding, and personalized medicine.

Experts share how this year's RAD Conference showcased cutting-edge advancements in atopic dermatitis to enhance patient care and treatment strategies.

Anabela Cardoso, MD, reflects on specific data from the phase 3b ADmirable trial evaluating the safety and efficacy of lebrikizumab in patients with moderate to severe AD and pigmented skin.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of July.

Unlock exclusive insights from SDPA 2025 and get expert pearls, emerging data, and clinical strategies at your fingertips. Share with us to access the full recap.

Catch up on coverage from the fourth and final day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.

Expert our review of the top pearls, clinical strategies, and practice-changing tips from leading voices in dermatology at SDPA’s 2025 Summer Conference.

Test your knowledge of key words, terms, and pearls associated with this weekend's SDPA Annual Summer Dermatology Conference.

From JAK inhibitors to trichoscopy and contact allergy clues, experts at SDPA 2025 shared their top clinical pearls for managing alopecia and hair loss.

A poster from SDPA 2025 showed brodalumab maintains a consistent safety profile with no completed suicides and low infection rates.

Eileen Cheever, MPAS, PA-C, highlights the growing role of JAK inhibitors in dermatology, including emerging data on prurigo nodularis and adolescent alopecia areata.

Maria Hordinsky, MD, urges dermatology clinicians to consider allergic contact dermatitis when scarring alopecia treatments fail.

Catch up on coverage from the third day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.